Syncom Formulations (India) share price
You have to be logged in to add this to Watchlist.- ₹15.00(0.40%)December 12, 2025 15:29:30 PM IST
- NSE
- BSE
- Vol : 1.24 M (NSE + BSE)Last 20 day avg : 1.22 M
Syncom Formulations (India) is trading 0.40% upper at Rs 15.00 as compared to its last closing price. Syncom Formulations (India) has been trading in the price range of 15.03 & 14.77. Syncom Formulations (India) has given -25.25% in this year & -2.35% in the last 5 days. Syncom Formulations (India) has TTM P/E ratio 23.39 as compared to the sector P/E of 25.61.The company posted a net profit of 16.60 Crores in its last quarter.Listed peers of Syncom Formulations (India) include Sun Pharmaceutical Industries (-0.69%), Torrent Pharmaceuticals (-0.56%), Divi's Laboratories (-0.27%).The Mutual Fund holding in Syncom Formulations (India) was at -% in . The MF holding has - from the last quarter. The FII holding in Syncom Formulations (India) was at 0.10% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 13, 2025, 11:21 PM UTC
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values4.11The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values21.70Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.67The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,794.50 | -0.69 | 4,30,478.68 | 37.94 | 6.04 | 0.88 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 3,780.00 | -0.56 | 1,27,870.05 | 66.64 | 16.92 | 0.84 | 17.62 |
| Divi's Laboratories | Bullish | 6,414.50 | -0.27 | 1,70,282.17 | 78.27 | 11.47 | 0.46 | 0.01 |
| Cipla | Neutral | 1,515.15 | 0.20 | 1,22,397.55 | 23.33 | 3.94 | 0.85 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,279.50 | 0.51 | 1,06,784.78 | 18.80 | 3.17 | 0.63 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-12 | Quarterly Results |
| 2025-08-08 | Quarterly Results & A.G.M. |
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results & Others |
| 2024-11-11 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE312C01025
- BSE Code524470
- NSE CodeSYNCOMF
Syncom Formulations (India) is trading at 15.00 as on Fri Dec 12 2025 09:59:30. This is 0.40% upper as compared to its previous closing price of 14.94.
The market capitalization of Syncom Formulations (India) is 1412.84 Cr as on Fri Dec 12 2025 09:59:30.
The 52 wk high for Syncom Formulations (India) is 23.95 whereas the 52 wk low is 14.10
Syncom Formulations (India) can be analyzed on the following key metrics -
- TTM P/E: 23.39
- Sector P/E: 25.61
- Dividend Yield: 0.00%
- D/E ratio: 0.00
Syncom Formulations (India) reported a net profit of 49.43 Cr in 2025.
EQUITY QUICK LINKS
Syncom Formulations (India) QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.